• Publications
  • Influence
HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm
Hugh Calkins, MD, FHRS; Josep Brugada, MD, FESC; Douglas L. Packer, MD, FHRS; Riccardo Cappato, MD, FESC; Shih-Ann Chen, MD, FHRS; Harry J. G. Crijns, MD, FESC; Ralph J. Damiano, Jr., MD; D. WynExpand
  • 1,784
  • 73
  • PDF
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up,
During the past decade, catheter ablation of atrial fibrillation (AF) has evolved rapidly from an investigational procedure to its current status as a commonly performed ablation procedure in manyExpand
  • 2,157
  • 72
  • PDF
Guidelines on management (diagnosis and treatment) of syncope.
Table of contents Preamble Scope of the document 1256 Method 1257 Part 1. Classification, epidemiology and prognosis Definition 1258 Brief overview of pathophysiology of syncope 1258 ClassificationExpand
  • 988
  • 47
  • PDF
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.
CONTEXT Treatment with antiarrhythmic drugs and anticoagulation is considered first-line therapy in patients with symptomatic atrial fibrillation (AF). Pulmonary vein isolation (PVI) withExpand
  • 973
  • 25
  • PDF
Left Atrial Appendage: An Underrecognized Trigger Site of Atrial Fibrillation
Background— Together with pulmonary veins, many extrapulmonary vein areas may be the source of initiation and maintenance of atrial fibrillation. The left atrial appendage (LAA) is an underestimatedExpand
  • 440
  • 21
Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
Background—Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a condition associated with the risk of sudden death (SD). Methods and Results—We conducted a multicenter study of theExpand
  • 516
  • 16
Guidelines on management (diagnosis and treatment) of syncope--update 2004.
Executive Summary ESC Committee for Practice Guidelines (CPG): Silvia G. Priori (Chairperson) (Italy), Maria Angeles Alonso Garcia (Spain), Jean-Jacques Blanc (France), Andrzej Budaj (Poland),Expand
  • 817
  • 15
  • PDF
Tilt table testing for assessing syncope
  • 562
  • 15
Diagnostic value of history in patients with syncope with or without heart disease.
OBJECTIVES We sought to establish what historical findings are predictive of the cause of syncope. BACKGROUND The clinical features of the various types of syncope have not been systematicallyExpand
  • 377
  • 12
  • PDF
Antiarrhythmic Effect of Statin Therapy and Atrial Fibrillation A Meta-Analysis of Randomized Controlled Trials.
The aim of this meta-analysis was to improve the evaluation of the possible antiarrhythmic effect of statins on atrial fibrillation (AF) incidence orrecurrence.
  • 167
  • 12
  • PDF